0001214659-19-003910.txt : 20190530 0001214659-19-003910.hdr.sgml : 20190530 20190530202629 ACCESSION NUMBER: 0001214659-19-003910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190529 FILED AS OF DATE: 20190530 DATE AS OF CHANGE: 20190530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boehm Rainer J. CENTRAL INDEX KEY: 0001732381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 19868249 MAIL ADDRESS: STREET 1: C/O HUMANIGEN, INC. STREET 2: 1000 MARINA BOULEVARD, SUITE 250 CITY: BRISBANE STATE: CA ZIP: 94005-1878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-45106.xml PRIMARY DOCUMENT X0306 4 2019-05-29 0001293310 HUMANIGEN, INC HGEN 0001732381 Boehm Rainer J. C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true false false false Common Stock, $0.001 par value 2019-05-29 4 A false 238625 0.665 A 317184 D Stock Option (Right to Buy) 0.665 2019-05-29 4 M false 238625 0 D 2018-06-30 2028-03-08 Common Stock 238625 477252 D The option vests in 12 ratable quarterly installments commencing June 30, 2018. /s/ Cameron Durrant, Attorney-in-Fact 2019-05-30